Cook Islands vs Costa Rica: Average non-HDL cholesterol levels
Cook Islands
3.7
in 2018
Costa Rica
3.7
in 2018
Cook Islands rank
12th
Costa Rica rank
12th
Average non-HDL cholesterol levels over time
- Cook Islands
- Costa Rica
How they compare
Cook Islands currently reports 3.7 against 3.7 in Costa Rica, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Cook Islands ahead.
Cook Islands ranks 12th and Costa Rica ranks 12th of 191 countries.
Across the 4 decades both report, Cook Islands averaged higher in 2 and Costa Rica in 2.
Head to head by decade
| Decade | Cook Islands | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4 | 3.66 | 0.34 | Cook Islands |
| 1990s | 3.97 | 3.89 | 0.08 | Cook Islands |
| 2000s | 3.87 | 4 | 0.13 | Costa Rica |
| 2010s | 3.74 | 3.84 | 0.1 | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Cook Islands or Costa Rica?
- Cook Islands, at 3.7 against 3.7 in Costa Rica as of 2018.
- What is the difference in average non-hdl cholesterol levels between Cook Islands and Costa Rica?
- 0, with Cook Islands ahead.
- How many years of comparable data are there for Cook Islands and Costa Rica?
- 39 years are reported by both, from 1980 to 2018.
- How do Cook Islands and Costa Rica rank globally for average non-hdl cholesterol levels?
- Cook Islands ranks 12th and Costa Rica ranks 12th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.